Female Libido Support
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 33% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Supplement Facts — Evidence Check
20 mg
(100% DV)
✅ 1.4× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
Hops Flower Extract
200 mg
Tribulus terrestris
150 mg
Mucuna pruriens
125 mg
125 mg
📊 Market median: 120.0mg (440 products)
📚 187 studies (Tier A: 1, B: 71)
Epimedium sagittatum
100 mg
Cayenne Pepper
30 mg
25 mg
📊 Market median: 50.0mg (57 products)
📚 17 studies — no high-quality reviews
5 mg
📊 Market median: 3.0mg (984 products)
📚 236 studies (Tier A: 2, B: 109)
Other Ingredients
Dicalcium Phosphate
Cellulose
Croscarmellose Sodium
Stearate
Hydroxypropyl Methylcellulose
FD&C Blue Lake #1
FD&C Red #3
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Women (not pregnant or lactating)
Adult Female (18 - 50 Years)
Product Information
📋 Directions for Use
Directions: Take 1 tablet of HerSolution as part of a daily regimen with 8 oz. of water.
⚠️ Warnings & Precautions
Warnings: Not for use by individuals under the age of 18 years. Keep out of reach of children.
As with any nutritional supplement, please consult your physician before using.
Do not take if pregnant or lactating.
Product Details
UPC / SKU
6 28043 00805 2
DSLD Entry Date
2025-08-22
Product Type
Other Combinations
Form
Tablet or Pill
Brand
HerSolution
DSLD ID
336112
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100